Marshall Wace, LLP Surmodics Inc Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$27.44 - $35.56 $235,243 - $304,855	-8,573 Reduced 16.31%	43,981 $1.29 Million
Q4 2023 Feb 14, 2024	SELL	$28.47 - $38.49 $261,639 - $353,723	-9,190 Reduced 14.88%	52,554 $1.91 Million
Q3 2023 Nov 14, 2023	BUY	$28.28 - $38.36 $15,242 - $20,676	539 Added 0.88%	61,744 $1.98 Million
Q2 2023 Aug 14, 2023	BUY	$17.67 - $31.31 $325,852 - $577,387	18,441 Added 43.12%	61,205 $1.92 Million
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $732,547 - $1.65 Million	42,764 New	42,764 $974,000
Q1 2022 May 16, 2022	SELL	$40.68 - $49.72 $70,173 - $85,767	-1,725 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$43.21 - $57.6 $74,537 - $99,360	1,725 New	1,725 $83,000
Q1 2021 May 17, 2021	SELL	$42.18 - $56.07 $1.15 Million - $1.53 Million	-27,202 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$35.18 - $43.52 $307,508 - $380,408	-8,741 Reduced 24.32%	27,202 $1.18 Million
Q3 2020 Nov 16, 2020	BUY	$37.98 - $48.72 $394,422 - $505,957	10,385 Added 40.63%	35,943 $1.4 Million
Q2 2020 Aug 13, 2020	SELL	$31.07 - $44.74 $849,826 - $1.22 Million	-27,352 Reduced 51.7%	25,558 $1.11 Million
Q1 2020 May 15, 2020	SELL	$22.46 - $42.24 $559,456 - $1.05 Million	-24,909 Reduced 32.01%	52,910 $1.76 Million
Q4 2019 Feb 14, 2020	SELL	$39.01 - $47.51 $838,910 - $1.02 Million	-21,505 Reduced 21.65%	77,819 $3.22 Million
Q3 2019 Nov 14, 2019	SELL	$38.66 - $47.41 $1.27 Million - $1.56 Million	-32,826 Reduced 24.84%	99,324 $4.54 Million
Q2 2019 Aug 14, 2019	BUY	$38.23 - $47.43 $3.05 Million - $3.79 Million	79,908 Added 152.96%	132,150 $5.71 Million
Q1 2019 May 14, 2019	SELL	$41.26 - $58.35 $225,815 - $319,349	-5,473 Reduced 9.48%	52,242 $2.27 Million
Q4 2018 Feb 14, 2019	BUY	$44.93 - $73.38 $2.59 Million - $4.24 Million	57,715 New	57,715 $2.73 Million

Others Institutions Holding SRDX

# of Institutions

124

Shares Held

13.2M

Call Options Held

25.5K

Put Options Held

3.4K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $539M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account